Projection of new thresholds for hypertension to outpatient clinic patients and impact of risk factors
a cross-sectional study
Keywords:
Blood pressure, Hypertension, GuidelineAbstract
BACKGROUND: The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines on hypertension management recommend new stage 1 hypertension thresholds (130-139/80-89 mmHg) for starting antihypertensive treatment. OBJECTIVE: To analyze the impact of the 2017 ACC/AHA guidelines on patients’ diagnoses within daily practice, in comparison with management using the 2018 European hypertension guidelines, regarding the new thresholds. DESIGN AND SETTING: Cross-sectional study conducted in a hypertension outpatient clinic at a tertiary-level public hospital. METHODS: The diagnosis of hypertension was defined separately using each guideline. The participants were patients who were attending the hypertension clinic, who were evaluated using the thresholds of two guidelines, based on cardiovascular risk factors, including age, gender, smoking status, diabetes melli-tus, dyslipidemia, obesity, osteoporosis, chronic renal failure and family history of hypertension. RESULTS: After adapting the guidelines to the blood pressure values of our sample, 74.5% (n = 277) of the patients were diagnosed as hypertensive according to the blood pressure classification of the European Society of Cardiology (ESC) guidelines published in 2018, while 91.1% (n = 339) of the patients were hyper-tensive according to the new 2017 ACC/AHA guidelines. Multivariate regression analysis revealed that the significant demographic and cardiovascular risk factors associated with hypertension, based on the 2018 European Society of Hypertension (ESH)/ESC guidelines, were age (odds ratio, OR: 1.027; 95% confidence interval, CI: 1.001-1.054; P = 0.042), obesity (OR: 4.534; 95% CI: 1.830-11.237; P = 0.001) and family history of hypertension (OR: 2.199; 95% CI: 1.252-3.862; P = 0.006). CONCLUSIONS: The factors associated with the definition of hypertension may vary through changing the threshold values.
Downloads
References
Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386(9995):801-12. PMID: 25832858; doi: 10.1016/S0140-6736(14)61468-9.
Whelton PK, Carey RM, Aronow WS, et al. 2017. ACC/AHA/AAPA/ABC/ ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269-324. PMID: 29133354; doi: 10.1161/HYP.0000000000000066.
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. PMID: 24352797; doi: 10.1001/ jama.2013.284427.
Wang TD. Our Stance towards the 2017 ACC/AHA High Blood Pressure Clinical Practice Guideline: Has the Pendulum Swung Too Far?. Acta Cardiol Sin. 2018;34(1):1-3. PMID: 29375218; doi: 10.6515/ ACS.201801_34(1).20171218A.
Ioannidis JPA. Diagnosis and Treatment of Hypertension in the 2017 ACC/AHA Guidelines and in the Real World. JAMA. 2018;319(2):115-6. PMID: 29242891; doi: 10.1001/jama.2017.19672.
Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159-219. PMID: 23771844; doi: 10.1093/eurheartj/eht151.
Williams B, Mancia G, Spiering W, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2018;36(12):2284-2309. PMID: 30379783; doi: 10.1097/ HJH.0000000000001961.
SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103-16. PMID: 26551272; doi: 10.1056/NEJMoa1511939.
Ettehad D, Emdin CA, Kiran A, Rahimi K. Blood pressure lowering for cardiovascular disease - Authors’ reply. Lancet. 2016;388(10040):126-7. PMID: 27411872; doi: 10.1016/S0140-6736(16)30669-9.
Muntner P, Carey RM, Gidding S, et al. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018;137(2):109-18. PMID: 29133599; doi: 10.1161/ CIRCULATIONAHA.117.032582.
Chris Crawford. AAFP Decides to Not Endorse AHA/ACC Hypertension Guideline. Available at: https://www.aafp.org/news/health-of-the-public/20171212notendorseaha-accgdlne.html. Accessed in 2019 (Oct 1).
Wang JG, Liu L. Global Impact of 2017 American College of Cardiology/ American Heart Association Hypertension Guidelines: A Perspective From China. Circulation. 2018;137(6):546-8. PMID: 29431657; doi: 10.1161/CIRCULATIONAHA.117.032890.
Anchala R, Kannuri NK, Pant H, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32(6):1170-7. PMID: 24621804; doi: 10.1097/HJH.0000000000000146.
Wander GS, Ram CVS. Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From India. Circulation. 2018;137(6):549-50. PMID: 29431658; doi: 10.1161/CIRCULATIONAHA.117.032877.
Association of Physicians of India. Indian guidelines on hypertension (I.G.H.) - III. 2013. J Assoc Physicians India. 2013;61(2 Suppl):6-36. PMID: 24475694.
Gupta R, Deedwania PC, Achari V, et al. Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control. Am J Hypertens. 2013;26(1):83-94. PMID: 23382331; doi: 10.1093/ajh/hps013
